ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,328Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 387

$721K Total Retail Price of All Prescriptions

Rank: 67 out of 387

678 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 678 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 678 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 13,059 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 705 624 1 3
LEVOTHYROXINE SODIUM 591 491 2 2
OMEPRAZOLE 468 404 3 4
PRAVASTATIN SODIUM 451 375 4 15
HYDROCODONE-ACETAMINOPHEN 399 292 S3 5 1
ATENOLOL 383 361 6 20
METOPROLOL TARTRATE 363 340 7 11
AMLODIPINE BESYLATE 338 285 8 6
GABAPENTIN 325 275 9 10
CITALOPRAM HBR 311 247 10 19
POTASSIUM CHLORIDE 287 279 11 9
SIMVASTATIN 266 240 12 5
FUROSEMIDE 262 228 13 7
WARFARIN SODIUM 236 221 14 17
ATORVASTATIN CALCIUM 233 203 15 13
METFORMIN HCL 232 203 16 8
METOPROLOL SUCCINATE 223 213 17 18
HYDROCHLOROTHIAZIDE 217 189 18 12
ZOLPIDEM TARTRATE 205 160 19 16
FLUTICASONE PROPIONATE 204 157 20 29
LOVASTATIN 186 186 21 36
ALENDRONATE SODIUM 158 148 22 31
PROAIR HFA 158 104 22 47
ALLOPURINOL 153 150 24 28
TRAMADOL HCL 146 136 25 14
AMLODIPINE BESYLATE-BENAZEPRIL 133 133 26 54
CLONIDINE HCL 132 128 27 38
DIGOXIN 123 111 28 40
TAMSULOSIN HCL 121 114 29 32
CARVEDILOL 121 104 29 21
SINGULAIR 114 78 31 83
CYCLOBENZAPRINE HCL 112 75 R 32 42
ADVAIR DISKUS 108 96 33 41
RANITIDINE HCL 101 76 34 45
TRIAMTERENE-HCTZ 97 92 35 55
ENALAPRIL MALEATE 96 96 36 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 90 37 30
PREDNISONE 90 64 38 43
NEXIUM 88 47 39 26
VENLAFAXINE HCL ER 86 66 40 97
PAROXETINE HCL 85 70 41 52
ESTRADIOL 84 67 R 42 105
SERTRALINE HCL 84 82 42 23
GLIMEPIRIDE 83 71 44 50
HYDRALAZINE HCL 81 77 45 94
TERAZOSIN HCL 81 80 45 109
TRAZODONE HCL 80 56 47 37
SPIRIVA 73 67 48 61
LANTUS SOLOSTAR 70 46 49 102
NIFEDICAL XL 70 67 49 221
MELOXICAM 69 60 51 22
CYMBALTA 69 57 51 44
PLAVIX 68 59 53 39
SYNTHROID 68 67 53 68
CLOPIDOGREL 68 66 53 25
VENTOLIN HFA 66 56 56 142
BUMETANIDE 65 59 57 247
VERAPAMIL ER 63 63 58 87
DOXYCYCLINE HYCLATE 63 55 58 114
LANSOPRAZOLE 63 51 58 141
NAPROXEN 59 38 61 89
GLYBURIDE 58 58 R 62 58
KLOR-CON M20 58 55 62 76
METOCLOPRAMIDE HCL 58 36 62 125
DONEPEZIL HCL 57 57 65 27
LOSARTAN POTASSIUM 55 50 66 24
BUPROPION HCL SR 52 35 67 158
DOXAZOSIN MESYLATE 52 46 67 75
CRESTOR 52 49 67 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.